Influenza virus uses its neuraminidase protein to evade the recognition of two activating NK cell receptors

Journal of Infectious Diseases

Volumn 210, Issue 3, 2014, Pages 410-418

  Bar On, Yotam ^a   Seidel, Einat ^a   Tsukerman, Pinchas ^a   Mandelboim, Michal ^b   Mandelboim, Ofer ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b MINISTRY OF HEALTH   (Israel)

Author keywords

Immune evasion; Influenza virus; Neuraminidase; NK cells; NKp44; NKp46

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NATURAL KILLER CELL RECEPTOR; SIALIC ACID; SIALIDASE; INTERLEUKIN 2; OSELTAMIVIR; VIRUS HEMAGGLUTININ; VIRUS SIALIDASE; ZANAMIVIR;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL ACTIVATION; CELL ACTIVITY; CELL KILLING; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNE EVASION; INFLUENZA VIRUS; MOLECULAR RECOGNITION; MOUSE; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; AMINO TERMINAL SEQUENCE; ANTIGEN BINDING; BIOTINYLATION; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN SECRETION; VIRUS INHIBITION; VIRUS NEUTRALIZATION; VIRUS RESISTANCE;

IMMUNE EVASION; INFLUENZA VIRUS; NEURAMINIDASE; NK CELLS; NKP44; NKP46;

ANIMALS; CELL LINE, TUMOR; HEMAGGLUTININS; HUMANS; INFLUENZA A VIRUS; MICE; NEURAMINIDASE; RECEPTORS, NATURAL KILLER CELL;

EID: 84904357529     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu094     Document Type: Article

References (40)

1. Stanietsky N, Simic H, Arapovic J, et al. The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity. Proc Natl Acad Sci U S A 2009; 106:17858-63.
2. Simhadri VR, Andersen JF, Calvo E, Choi SC, Coligan JE, Borrego F. Human CD300a binds to phosphatidylethanolamine and phosphatidylserine, and modulates the phagocytosis of dead cells. Blood 2012; 119:2799-809.
3. Long EO, Kim HS, Liu D, Peterson ME, Rajagopalan S. Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol 2013; 31:227-58.
4. Hosomi S, Chen Z, Baker K, et al. CEACAM1 on activated NK cells inhibits NKG2D-mediated cytolytic function and signaling. Eur J Immunol 2013; 43:2473-83.
5. Kirwan SE, Burshtyn DN. Regulation of natural killer cell activity. Curr Opin Immunol 2007; 19:46-54.
6. Lankry D, Rovis TL, Jonjic S, Mandelboim O. The interaction between CD300a and phosphatidylserine inhibits tumor cell killing by NK cells. Eur J Immunol 2013; 43:2151-61.
7. Moretta A, Bottino C, Vitale M, et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001; 19:197-223.
8. Cantoni C, Ponassi M, Biassoni R, et al. The three-dimensional structure of the human NK cell receptor NKp44, a triggering partner in natural cytotoxicity. Structure 2003; 11:725-34.
9. Seidel E, Glasner A, Mandelboim O. Virus-mediated inhibition of natural cytotoxicity receptor recognition. CMLS 2012; 69:3911-20.
10. Gazit R, Gruda R, Elboim M, et al. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat Immunol 2006; 7:517-23.
11. Biassoni R, Pessino A, Bottino C, Pende D, Moretta L, Moretta A. The murine homologue of the human NKp46, a triggering receptor involved in the induction of natural cytotoxicity. Eur J Immunol 1999; 29:1014-20.
12. Marras F, Bozzano F, De Maria A. Involvement of activating NK cell receptors and their modulation in pathogen immunity. BioMed Res Int 2011; 2011:152430.
13. Cantoni C, Bottino C, Vitale M, et al. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J Exp Med 1999; 189:787-96.
14. Hanna J, Goldman-Wohl D, Hamani Y, et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med 2006; 12:1065-74.
15. Ho JW, Hershkovitz O, Peiris M, et al. H5-type influenza virus hemagglutinin is functionally recognized by the natural killer-activating receptor NKp44. J Virol 2008; 82:2028-32.
16. Arnon TI, Lev M, Katz G, Chernobrov Y, Porgador A, Mandelboim O. Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur J Immunol 2001; 31:2680-9.
17. Jarahian M, Watzl C, Fournier P, et al. Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase. J Virol 2009; 83:8108-21.
18. Rosental B, Brusilovsky M, Hadad U, et al. Proliferating cell nuclear antigen is a novel inhibitory ligand for the natural cytotoxicity receptor NKp44. J Immunol 2011; 187:5693-702.
19. Baychelier F, Sennepin A, Ermonval M, Dorgham K, Debre P, Vieillard V. Identification of a cellular ligand for the natural cytotoxicity receptor NKp44. Blood 2013; 122:2935-42.
20. Arnon TI, Markel G, Mandelboim O. Tumor and viral recognition by natural killer cells receptors. Semin Cancer Biol 2006; 16:348-58.
21. Madrid AS, Ganem D. Kaposi's sarcoma-associated herpesvirus ORF54/dUTPase downregulates a ligand for the NK activating receptor NKp44. J Virol 2012; 86:8693-704.
22. Hershkovitz O, Rosental B, Rosenberg LA, et al. NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells. J Immunol 2009; 183:2610-21.
23. Vieillard V, Strominger JL, Debre P. NK cytotoxicity against CD4+ T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand. Proc Natl Acad Sci U S A 2005; 102:10981-6.
24. Pende D, Parolini S, Pessino A, et al. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J Exp Med 1999; 190:1505-16.
25. Mandelboim O, Lieberman N, Lev M, et al. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 2001; 409:1055-60.
26. Arnon TI, Achdout H, Lieberman N, et al. The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46. Blood 2004; 103:664-72.
27. Achdout H, Meningher T, Hirsh S, et al. Killing of avian and swine influenza virus by natural killer cells. J virol 2010; 84:3993-4001.
28. Mendelson M, Tekoah Y, Zilka A, et al. NKp46 O-glycan sequences that are involved in the interaction with hemagglutinin type 1 of influenza virus. J virol 2010; 84:3789-97.
29. Glasner A, Zurunic A, Meningher T, et al. Elucidating the mechanisms of influenza virus recognition by Ncr1. PLoS One 2012; 7:e36837.
30. Jarahian M, Fiedler M, Cohnen A, et al. Modulation of NKp30- and NKp46-mediated natural killer cell responses by poxviral hemagglutinin. PLoS Pathog 2011; 7:e1002195.
31. Bar-On Y, Glasner A, Meningher T, et al. Neuraminidase-mediated, NKp46-dependent immune-evasion mechanism of influenza viruses. Cell Rep 2013; 3:1044-50.
32. Achdout H, Arnon TI, Markel G, et al. Enhanced recognition of human NK receptors after influenza virus infection. J Immunol 2003; 171:915-23.
33. Mandelboim O, Reyburn HT, Vales-Gomez M, et al. Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J Exp Med 1996; 184:913-22.
34. Stern-Ginossar N, Elefant N, Zimmermann A, et al. Host immune system gene targeting by a viral miRNA. Science 2007; 317:376-81.
35. Nachmani D, Stern-Ginossar N, Sarid R, Mandelboim O. Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell Host Microbe 2009; 5:376-85.
36. Nachmani D, Lankry D, Wolf DG, Mandelboim O. The human cytomegalovirus microRNA miR-UL112 acts synergistically with a cellular microRNA to escape immune elimination. Nat Immunol 2010; 11:806-13.
37. Fernandez-Messina L, Reyburn HT, Vales-Gomez M. Human NKG2D-ligands: cell biology strategies to ensure immune recognition. Front Immunol 2012; 3:299.
38. Wilkinson GW, Tomasec P, Stanton RJ, et al. Modulation of natural killer cells by human cytomegalovirus. J Clin Virol 2008; 41:206-12.
39. Arnon TI, Achdout H, Levi O, et al. Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nat Immunol 2005; 6:515-23.
40. Nayak DP, Hui EK, Barman S. Assembly and budding of influenza virus. Virus Res 2004; 106:147-65.